These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 6351379)
21. Influence of tumor necrosis factor-alpha on the ability of monocytes and lymphocytes to destroy intraerythrocytic Plasmodium falciparum in vitro. Muniz-Junqueira MI; dos Santos-Neto LL; Tosta CE Cell Immunol; 2001 Mar; 208(2):73-9. PubMed ID: 11333139 [TBL] [Abstract][Full Text] [Related]
23. Induction of crisis forms in the human malaria parasite Plasmodium falciparum by gamma-interferon-activated, monocyte-derived macrophages. Ockenhouse CF; Schulman S; Shear HL J Immunol; 1984 Sep; 133(3):1601-8. PubMed ID: 6431003 [TBL] [Abstract][Full Text] [Related]
24. Evaluation of in-vitro-cultured Plasmodium falciparum as antigen for malaria serology. Gupta MM; Sebastian MJ; Bhat P; Lobel HO J Trop Med Hyg; 1981 Aug; 84(4):165-70. PubMed ID: 7021870 [TBL] [Abstract][Full Text] [Related]
25. Evaluation of a crude soluble antigen from in-vitro culture of Plasmodium falciparum for ELISA. Francis VS; Gupta MM; Bhat P Tropenmed Parasitol; 1982 Dec; 33(4):240-2. PubMed ID: 6761915 [TBL] [Abstract][Full Text] [Related]
26. Delayed parasite elimination in human infections treated with clindamycin parallels 'delayed death' of Plasmodium falciparum in vitro. Burkhardt D; Wiesner J; Stoesser N; Ramharter M; Uhlemann AC; Issifou S; Jomaa H; Krishna S; Kremsner PG; Borrmann S Int J Parasitol; 2007 Jun; 37(7):777-85. PubMed ID: 17280676 [TBL] [Abstract][Full Text] [Related]
27. [Preliminary study of a recombinant polyvalent vaccine of Plasmodium falciparum and its immunological activity]. Li Q; Li Y; Xie Y Zhonghua Yi Xue Za Zhi; 1995 Jun; 75(6):325-8, 381. PubMed ID: 7553140 [TBL] [Abstract][Full Text] [Related]
29. Role of heat-labile serum factor or host complement in the inhibition of Plasmodium falciparum sporogonic stages in Anopheles stephensi by gametocyte carriers' serological factors. Gouagna LC; van der Kolk M; Roeffen W; Verhave JP; Eling W; Sauerwein R; Boudin C Parasitology; 2007 Sep; 134(Pt 10):1315-27. PubMed ID: 17645813 [TBL] [Abstract][Full Text] [Related]
30. Natural killer (NK) cell-mediated cytolysis of Plasmodium falciparum-infected human red blood cells in vitro. Mavoungou E; Luty AJ; Kremsner PG Eur Cytokine Netw; 2003; 14(3):134-42. PubMed ID: 14656686 [TBL] [Abstract][Full Text] [Related]
32. Autoantibodies in sera of Thai patients with Plasmodium falciparum infection. Boonpucknavig S; Ekapanyakul G Clin Exp Immunol; 1984 Oct; 58(1):77-82. PubMed ID: 6383670 [TBL] [Abstract][Full Text] [Related]
33. Detection of Plasmodium falciparum derived macrophage migration inhibitory factor homologue in the sera of malaria patients. Shao D; Han Z; Lin Y; Zhang L; Zhong X; Feng M; Guo Y; Wang H Acta Trop; 2008 Apr; 106(1):9-15. PubMed ID: 18262164 [TBL] [Abstract][Full Text] [Related]
34. IgG(4) Pf NPNA-1 a human anti-Plasmodium falciparum sporozoite monoclonal antibody cloned from a protected individual inhibits parasite invasion of hepatocytes. Chappel JA; Hollingdale MR; Kang AS Hum Antibodies; 2004; 13(3):91-6. PubMed ID: 15598989 [TBL] [Abstract][Full Text] [Related]
35. Differential effect and interaction of monocytes, hyperimmune sera, and immunoglobulin G on the growth of asexual stage Plasmodium falciparum parasites. Shi YP; Udhayakumar V; Oloo AJ; Nahlen BL; Lal AA Am J Trop Med Hyg; 1999 Jan; 60(1):135-41. PubMed ID: 9988337 [TBL] [Abstract][Full Text] [Related]
36. Soluble serum antigens of P. falciparum in Nigerians. I. Local incidence of malarial soluble serum antigens and antibodies. Williams AI; Houba V Afr J Med Sci; 1972 Oct; 3(4):295-307. PubMed ID: 4628791 [No Abstract] [Full Text] [Related]
37. Comparison of various serological test results using antigens from different strains of Plasmodium falciparum. Tharavanij S; Tantivanich S; Chongsa-Nguan M; Prasertsiriroj V Southeast Asian J Trop Med Public Health; 1982 Jun; 13(2):174-80. PubMed ID: 6183756 [TBL] [Abstract][Full Text] [Related]
38. Characterisation of the host response to Plasmodium falciparum infection in acute non-complicated malaria. Cowen NL; Clancy RL; Stace J; Cripps AW; Alpers MP Aust J Exp Biol Med Sci; 1986 Jun; 64 ( Pt 3)():229-35. PubMed ID: 3533020 [TBL] [Abstract][Full Text] [Related]
39. Characterization of the humoral immune response in Plasmodium falciparum malaria. II. IgG subclass levels of anti-P. falciparum antibodies in different sera. Wahlgren M; Berzins K; Perlmann P; Persson M Clin Exp Immunol; 1983 Oct; 54(1):135-42. PubMed ID: 6352103 [TBL] [Abstract][Full Text] [Related]
40. Inhibitory factors in breastmilk, maternal and infant sera against in vitro growth of Plasmodium falciparum malaria parasite. Kassim OO; Ako-Anai KA; Torimiro SE; Hollowell GP; Okoye VC; Martin SK J Trop Pediatr; 2000 Apr; 46(2):92-6. PubMed ID: 10822935 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]